Class Actions

The funder in the Opal Tower class action has appealed a judge’s decision to slash its commission for not disclosing proposed deductions from the settlement sum as percentages, telling the Full Court that group members could do “simple arithmetic”.

A ground-breaking class action has been filed in Victoria against the AFL seeking compensation for former players who sustained concussion-related injuries during games.

Shareholders have brought a class action in Australia against New Zealand-based Fletcher Building, alleging the company failed to disclose material information relating to its construction division.

A judge overseeing a security dispute in a shareholder class action against KPMG and former directors of Arrium has found that potential profits to the plaintiff law firm running the case under a group costs order is not relevant to determining the quantum of security for costs.

The question of whether judges have the power to hear employment cases as representative proceedings is headed to the Full Court after a union raised the issue as it battles to have its underpayments case against McDonald’s run instead of a Shine Lawyers class action.

A judge is weighing up a law firm’s high legal costs against a union’s “bizarre” delay in a stoush over who should run a case against McDonald’s alleging 100,000 workers were denied rest breaks. 

The fees of a class action firm found to have breached cost disclosure rules in running two underpayments class actions against supermarket chain Romeo’s have been adjusted up, after $260,000 was initially cut from the bill by the Federal Court.

A class action against Bayer over its Essure contraceptive has lost a bid to knock out the pharmaceutical giant’s defence that argues any defects in the device could not have been discovered given the state of scientific knowledge at the time the implants were sold in Australia.

A busy judge has pushed the parties in a class action against agrochemical giant Monsanto to split the trial to focus first on the question of whether the company’s Roundup weed killer causes cancer so that he can avoid writing a judgment of “hundreds and hundreds” of pages.

Pet and livestock drug company Zoetis, which prevailed in its defence to a class action over horse vaccine Equivac, is going after the legal team that ran the unfunded case, seeking orders that the lawyers pay a big portion of its $3.8 million legal bill.